<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id><journal-title-group>
<journal-title>Frontiers in Cardiovascular Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cardiovasc. Med.</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2297-055X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcvm.2026.1736628</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Analysis of the value of nutritional status indexes (ALB, Hb, GNRI) in prognostic assessment of elderly patients with chronic heart failure</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Xue</surname><given-names>Meng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Conghan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Lei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role></contrib>
<contrib contrib-type="author"><name><surname>Gao</surname><given-names>Jianxiang</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Zhangsun</surname><given-names>Yanling</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/3263206/overview"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Cardiology, Xi&#x0027;an People&#x2019;s Hospital (Xi&#x0027;an Fourth Hospital)</institution>, <city>Xi&#x2019;an</city>, <country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>Department of General Practice, Xi&#x0027;an People&#x2019;s Hospital (Xi&#x0027;an Fourth Hospital)</institution>, <city>Xi&#x2019;an</city>, <country country="cn">China</country></aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Yanling Zhangsun <email xlink:href="mailto:lryzs421@163.com">lryzs421@163.com</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-24"><day>24</day><month>02</month><year>2026</year></pub-date>
<pub-date publication-format="electronic" date-type="collection"><year>2026</year></pub-date>
<volume>13</volume><elocation-id>1736628</elocation-id>
<history>
<date date-type="received"><day>31</day><month>10</month><year>2025</year></date>
<date date-type="rev-recd"><day>05</day><month>02</month><year>2026</year></date>
<date date-type="accepted"><day>06</day><month>02</month><year>2026</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2026 Xue, Wang, Wang, Gao and Zhangsun.</copyright-statement>
<copyright-year>2026</copyright-year><copyright-holder>Xue, Wang, Wang, Gao and Zhangsun</copyright-holder><license><ali:license_ref start_date="2026-02-24">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license>
</permissions>
<abstract><sec><title>Objective</title>
<p>This study evaluated the prognostic value of nutritional status indexes [albumin (ALB), hemoglobin (Hb), Geriatric Nutritional Risk Index (GNRI)] in elderly chronic heart failure (CHF) patients.</p>
</sec><sec><title>Methods</title>
<p>A total of 190 elderly CHF patients were categorized into good (<italic>n</italic>&#x2009;&#x003D;&#x2009;142) and poor (<italic>n</italic>&#x2009;&#x003D;&#x2009;48) prognosis groups based on 1-year outcomes (rehospitalization or all-cause death). Clinical data, including cardiac function [New York Heart Association (NYHA) class], inflammatory markers, and nutritional indexes (ALB, Hb, GNRI), were analyzed. Spearman correlation was used to assess the relationship between nutritional markers and NYHA class. Patients were stratified by median ALB, Hb, and GNRI levels to compare poor prognosis incidence. Kaplan&#x2013;Meier survival and Cox regression analyses identified prognostic factors, while Receiver Operating Characteristic (ROC) curves evaluated predictive performance.</p>
</sec><sec><title>Results</title>
<p>The poor prognosis group exhibited significantly lower ALB, Hb, and GNRI levels (<italic>P</italic>&#x2009;&#x003C;&#x2009;0.001). These markers declined with worsening NYHA class (<italic>P</italic>&#x2009;&#x003C;&#x2009;0.001) and correlated negatively with cardiac function. Low ALB, Hb, and GNRI groups had higher poor prognosis rates (<italic>P</italic>&#x2009;&#x003C;&#x2009;0.001), confirmed by Kaplan&#x2013;Meier analysis. Cox regression identified left ventricular ejection fraction (LVEF), N-terminal pro-B-type natriuretic peptide (NT-proBNP), NYHA class, ALB, Hb, and GNRI as independent prognostic factors. ROC analysis showed ALB [area under the curve (AUC)&#x2009;&#x003D;&#x2009;0.845], Hb (AUC&#x2009;&#x003D;&#x2009;0.884), and GNRI (AUC&#x2009;&#x003D;&#x2009;0.896) as strong predictors with high sensitivity/specificity.</p>
</sec><sec><title>Conclusion</title>
<p>Reduced ALB, Hb, and GNRI levels are associated with poor CHF prognosis in elderly patients. These nutritional indexes offer reliable predictive value for clinical prognosis assessment.</p>
</sec>
</abstract>
<kwd-group>
<kwd>chronic heart failure in the elderly</kwd>
<kwd>Cox regression analysis</kwd>
<kwd>geriatric nutritional risk index</kwd>
<kwd>nutritional status indexes</kwd>
<kwd>prognosis</kwd>
<kwd>ROC</kwd>
</kwd-group><funding-group><funding-statement>The author(s) declared that financial support was not received for this work and/or its publication.</funding-statement></funding-group><counts>
<fig-count count="4"/>
<table-count count="3"/><equation-count count="0"/><ref-count count="37"/><page-count count="10"/><word-count count="0"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Heart Failure and Transplantation</meta-value></custom-meta></custom-meta-group>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><title>Introduction</title>
<p>Chronic heart failure (CHF) is a common and complex clinical syndrome in the field of cardiovascular disease, characterized by a weakened pumping function of the heart, which is unable to meet the body&#x0027;s metabolic demands (<xref ref-type="bibr" rid="B1">1</xref>). With the increasing trend of global population aging, the incidence of CHF in the elderly population has been increasing year by year, and it has become one of the major causes affecting the quality of life of the elderly (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Despite the advances in medical technology in recent years, the morbidity, mortality, and rehospitalization rates of elderly CHF patients remain high, which not only imposes a heavy financial burden on patients&#x2019; families, but also exerts tremendous pressure on healthcare resources (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>Malnutrition is a state of energy or nutrient deficiency caused by inadequate intake or impaired utilization. Malnutrition is associated with decreased functional status, impaired muscle function, decreased bone mass, immune dysfunction, anemia, decreased cognitive function, poor wound healing, delayed recovery from surgery, higher rates of hospitalization and readmission, and mortality, resulting in significant harm and economic burden for both the individual older adult and the family (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Studies have shown that nutritional status is closely related to the prognosis of many diseases, especially for elderly patients with CHF, and malnutrition may be one of the important risk factors for poor outcomes (<xref ref-type="bibr" rid="B8">8</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>). Malnutrition leads to loss of muscle, adipose tissue, and bone mass, which increases the risk of death and the probability of rehospitalization in patients (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). Therefore, accurate assessment of the nutritional status of elderly patients with CHF is important for the development of individualized treatment plans and improvement of patient prognosis.</p>
<p>Currently, commonly used nutritional assessment indicators in clinical practice include serum albumin (ALB), hemoglobin (Hb), and Geriatric Nutritional Risk Index (GNRI) (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). Among them, ALB, as an important marker of protein nutritional status, has been widely used in the prognostic assessment of many diseases (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>); Hb level is closely related to anemia, which is a common and important complication in patients with chronic heart failure (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>); GNRI, as a comprehensive evaluation of the nutritional status of the index, can quickly assess the nutritional status of patients without additional GNRI is of high practical value as a comprehensive indicator of nutritional status that can rapidly assess the nutritional risk of patients without additional tests (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>However, there is a lack of systematic research on the specific role of these nutritional status indicators in elderly patients with chronic heart failure. The aim of this study is to retrospectively analyze the clinical data of elderly patients with chronic heart failure, to investigate the effects of ALB, Hb and GNRI on the prognosis of the patients, to clarify their predictive value in the elderly CHF population, and to provide a scientific basis for clinical practice.</p>
</sec>
<sec id="s2" sec-type="methods"><title>Materials and methods</title>
<sec id="s2a"><title>Study design and participants</title>
<p>This was a single-center, retrospective observational study. Consecutive sampling was employed, whereby all elderly patients diagnosed with CHF who were admitted to Xi&#x0027;an People&#x0027;s Hospital (Xi&#x0027;an Fourth Hospital) between January 2022 and January 2024 were initially screened. A total of 228 patients were assessed for eligibility. After applying the inclusion and exclusion criteria, 190 elderly CHF patients were finally enrolled as study subjects. The patients were categorized into good prognosis group (<italic>n</italic>&#x2009;&#x003D;&#x2009;142) and poor prognosis group (<italic>n</italic>&#x2009;&#x003D;&#x2009;48) based on the presence or absence of re-admission for heart failure or all-cause mortality at 1 year of follow-up. This study was conducted in accordance with the Declaration of Helsinki and was reviewed and approved by the Ethics Committee of Xi&#x0027;an People&#x0027;s Hospital (Xi&#x0027;an Fourth Hospital). The requirement for individual informed consent was waived by the ethics committee for this retrospective analysis of anonymized clinical data.</p>
</sec>
<sec id="s2b"><title>Inclusion criteria</title>
<p>(1) Met the diagnostic criteria for chronic heart failure (<xref ref-type="bibr" rid="B21">21</xref>); (2) Age &#x2265; 60 years old; (3) Complete clinical and pathological data and follow-up data.</p>
</sec>
<sec id="s2c"><title>Exclusion criteria</title>
<p>Presence of malignant tumors in other parts of the body; (2) Severe damage to vital organs such as heart, brain, liver, and kidneys; (3) Transfusion of albumin or other blood products in the last week; (4) Hormone or immunosuppressant users in the last 3 months; (5) Incomplete clinical information.</p>
</sec>
<sec id="s2d"><title>Collecting information</title>
<p>Clinical baseline data of all elderly CHF patients were collected and organized, including age, gender, smoking history, drinking history, hypertension, hyperlipidemia, diabetes, Cardiac ultrasound values left atrial diameter (LAD), left ventricular end-systolic diameter (LVDs), left ventricular end-diastolic diameter (LVDd), left ventricular ejection fraction (LVEF), serum high-sensitivity C-reactive protein (hs-CRP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), and New York Heart Association (NYHA) cardiac function class, serum albumin (ALB), hemoglobin (Hb) levels, etc. Doppler echocardiography was performed to detect cardiac echocardiographic indices using a PHILIPS Affiniti 70W (IL, USA) to record LAD, LVDs, LVDd, and LVEF.</p>
<p>Fasting elbow venous blood (5&#x2005;mL) was collected from all patients on the early morning of admission, placed in a vacuum blood collection tube without anticoagulant, and naturally agglutinated at room temperature for 30&#x2005;min. After blood coagulation, the samples were centrifuged at 2,000&#x2005;r/min for 20&#x2005;min, and the upper serum was collected and stored at &#x2212;80&#x2005;&#x00B0;C for backup testing. The kits for serum ALB, hs-CRP, and NT-proBNP were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). The Hb detection kit was provided by Tianjin Yueteng Biotechnology Co., Ltd. (Tianjin, China). All detections were performed strictly in accordance with the kit instructions, and the instruments used were calibrated regularly to ensure the reliability of test results.</p>
<p>According to the NYHA functional class, the cardiac function class of the enrolled patients was II-IV. In addition, the Geriatric Nutritional Risk Index (GNRI) was calculated according to the formula (<xref ref-type="bibr" rid="B22">22</xref>): GNRI&#x2009;&#x003D;&#x2009;1.489&#x2009;&#x00D7;&#x2009;serum albumin (g/L)&#x2009;&#x002B;&#x2009;41.7 &#x00D7;&#x2009;actual weight (kg)/ideal weight. Ideal weight was calculated using the Lorenz formula: height (cm)&#x2212;100&#x2212;[height (cm)&#x2212;150]/4) for men and height (cm)&#x2212;100&#x2212;[height (cm)&#x2212;150]/2.5) for women.</p>
</sec>
<sec id="s2e"><title>Follow-up and prognostic evaluation</title>
<p>Elderly patients with CHF were discharged from the hospital and followed up by outpatient clinic or telephone for 1 year and every 3 months. The follow-up time end point was set to January 2025, and the occurrence of another heart failure admission or all-cause death was defined as poor prognosis, and the incidence of poor prognosis in patients was counted.</p>
</sec>
<sec id="s2f"><title>Statistical analysis</title>
<p>A <italic>post-hoc</italic> power analysis was performed using G&#x002A;Power software (version 3.1). With a two-sided alpha of 0.05, effect size d&#x2009;&#x003D;&#x2009;0.5, and the actual sample sizes (good prognosis group: <italic>n</italic>&#x2009;&#x003D;&#x2009;142; poor prognosis group: <italic>n</italic>&#x2009;&#x003D;&#x2009;48), the achieved statistical power (1&#x2014;&#x03B2;) was 0.85, which exceeds the conventional threshold of 0.80 for cohort studies, indicating adequate sample size for statistical inference regarding the primary outcome. GraphPad Prism 9.5.0 software (GraphPad Software Inc., San Diego, CA, USA) and SPSS 27.0 statistical software (SPSS, Inc, Chicago, IL, USA) were used for statistical analysis and graphing of data. The Shapiro&#x2013;Wilk test was used to test for normal distribution; normally distributed measures were expressed as mea<italic>n</italic>&#x2009;&#x00B1;&#x2009;standard deviation, independent samples <italic>t</italic>-tests were used between two groups, and one-way ANOVA analyses were used between multiple groups; non-normally distributed measures were expressed as median (interquartile range), and Mann&#x2013;Whitney U test was used for comparison between two groups, and multiple groups Kruskal&#x2013;Wallis test was used. Count data were expressed as number of cases and percentage using Chi-square test. Spearman correlation coefficient analysis was used to assess the correlation between the indicators. Kaplan&#x2013;Meier test and log-rank test for comparison of distributions were used to plot the curve of poor prognosis in elderly CHF patients. Cox regression was used to analyze the factors influencing the prognosis of elderly CHF patients. ROC curves were used to assess the predictive value of nutritional status indexes (ALB, Hb, GNRI) on poor prognosis in elderly CHF patients. <italic>P</italic> values were obtained from two-sided tests, and <italic>P</italic>&#x2009;&#x003C;&#x2009;0.05 was considered a statistically significant difference.</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><title>Results</title>
<sec id="s3a"><title>Clinical baseline characteristics of the enrolled population</title>
<p>In this study, 190 elderly patients with CHF were included as research subjects and were divided into a good prognosis group (<italic>n</italic>&#x2009;&#x003D;&#x2009;142) and a poor prognosis group (<italic>n</italic>&#x2009;&#x003D;&#x2009;48) according to the prognosis of the patients. Comparative analysis of the clinical baseline data of the two groups of patients was performed and analyzed, as shown in <xref ref-type="table" rid="T1">Table&#x00A0;1</xref>, there were no significant differences in terms of age, gender, smoking history, drinking history, hypertension, hyperlipidemia, diabetes, and LAD (all <italic>P</italic>&#x2009;&#x003E;&#x2009;0.05), but there were significant differences in LVDs, LVDd, LVEF, hs-CRP, NT-proBNP and NYHA cardiac function class (all <italic>P</italic>&#x2009;&#x003C;&#x2009;0.05).</p>
<table-wrap id="T1" position="float"><label>Table&#x00A0;1</label>
<caption><p>Clinical baseline information of the enrolled population.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Variable</th>
<th valign="top" align="center">Good prognosis group (<italic>n</italic>&#x2009;&#x003D;&#x2009;142)</th>
<th valign="top" align="center">Poor prognosis group (<italic>n</italic>&#x2009;&#x003D;&#x2009;48)</th>
<th valign="top" align="center">t/<italic>&#x03C7;</italic>2/Z</th>
<th valign="top" align="center"><italic>P</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age (years)</td>
<td valign="top" align="center">72.82&#x2009;&#x00B1;&#x2009;3.52</td>
<td valign="top" align="center">73.50&#x2009;&#x00B1;&#x2009;3.56</td>
<td valign="top" align="center">1.147</td>
<td valign="top" align="center">0.253</td>
</tr>
<tr>
<td valign="top" align="left">Gender (<italic>n</italic>, &#x0025;)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Male</td>
<td valign="top" align="center">81 (57.04&#x0025;)</td>
<td valign="top" align="center">29 (60.42&#x0025;)</td>
<td valign="top" align="center" rowspan="2">0.168</td>
<td valign="top" align="center" rowspan="2">0.682</td>
</tr>
<tr>
<td valign="top" align="left">Female</td>
<td valign="top" align="center">61 (42.96&#x0025;)</td>
<td valign="top" align="center">19 (39.58&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Smoking history (n, &#x0025;)</td>
<td valign="top" align="center">58 (40.85&#x0025;)</td>
<td valign="top" align="center">21 (43.75&#x0025;)</td>
<td valign="top" align="center">0.125</td>
<td valign="top" align="center">0.724</td>
</tr>
<tr>
<td valign="top" align="left">Drinking history (n, &#x0025;)</td>
<td valign="top" align="center">48 (33.80&#x0025;)</td>
<td valign="top" align="center">18 (37.50&#x0025;)</td>
<td valign="top" align="center">0.216</td>
<td valign="top" align="center">0.642</td>
</tr>
<tr>
<td valign="top" align="left">Hypertension (n, &#x0025;)</td>
<td valign="top" align="center">63 (44.37&#x0025;)</td>
<td valign="top" align="center">23 (47.92&#x0025;)</td>
<td valign="top" align="center">0.183</td>
<td valign="top" align="center">0.669</td>
</tr>
<tr>
<td valign="top" align="left">Hyperlipidemia (n, &#x0025;)</td>
<td valign="top" align="center">43 (30.28&#x0025;)</td>
<td valign="top" align="center">17 (35.42&#x0025;)</td>
<td valign="top" align="center">0.438</td>
<td valign="top" align="center">0.508</td>
</tr>
<tr>
<td valign="top" align="left">Diabetes (n, &#x0025;)</td>
<td valign="top" align="center">18 (12.68&#x0025;)</td>
<td valign="top" align="center">7 (14.58&#x0025;)</td>
<td valign="top" align="center">0.114</td>
<td valign="top" align="center">0.735</td>
</tr>
<tr>
<td valign="top" align="left">Cardiac ultrasound values</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">LAD (mm)</td>
<td valign="top" align="center">37.00 (36.00, 38.00)</td>
<td valign="top" align="center">37.00 (36.00, 38.00)</td>
<td valign="top" align="center">&#x2212;0.237</td>
<td valign="top" align="center">0.815</td>
</tr>
<tr>
<td valign="top" align="left">LVDs (mm)</td>
<td valign="top" align="center">36.00 (36.00, 37.00)</td>
<td valign="top" align="center">38.00 (37.00, 39.75)</td>
<td valign="top" align="center">&#x2212;6.328</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">LVDd (mm)</td>
<td valign="top" align="center">51.00 (50.00, 51.00)</td>
<td valign="top" align="center">53.00 (52.00, 54.00)</td>
<td valign="top" align="center">&#x2212;8.547</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">LVEF (&#x0025;)</td>
<td valign="top" align="center">49.42&#x2009;&#x00B1;&#x2009;3.60</td>
<td valign="top" align="center">46.85&#x2009;&#x00B1;&#x2009;3.21</td>
<td valign="top" align="center">4.372</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">hs-CRP (mg/L)</td>
<td valign="top" align="center">5.83&#x2009;&#x00B1;&#x2009;0.70</td>
<td valign="top" align="center">7.09&#x2009;&#x00B1;&#x2009;1.08</td>
<td valign="top" align="center">9.293</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">NT-proBNP (ng/L)</td>
<td valign="top" align="center">672.10&#x2009;&#x00B1;&#x2009;25.88</td>
<td valign="top" align="center">861.00&#x2009;&#x00B1;&#x2009;33.36</td>
<td valign="top" align="center">40.510</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">NYHA Cardiac Function Classification</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">II</td>
<td valign="top" align="center">86 (60.56&#x0025;)</td>
<td valign="top" align="center">1 (2.08&#x0025;)</td>
<td valign="top" align="center" rowspan="3">103.620</td>
<td valign="top" align="center" rowspan="3">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">III</td>
<td valign="top" align="center">51 (35.92&#x0025;)</td>
<td valign="top" align="center">14 (29.17&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">IV</td>
<td valign="top" align="center">5 (3.52&#x0025;)</td>
<td valign="top" align="center">33 (68.75&#x0025;)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TF1"><p>LAD: left atrial diameter; LVDs: left ventricular end-systolic diameter; LVDd: left ventricular end-diastolic diameter; LVEF: left ventricular ejection fraction; hs-CRP: high-sensitivity C-reactive Protein; NT-proBNP: N-terminal pro-B-type natriuretic peptide; NYHA: New York Heart Association. Association. Counting data were expressed as the number of cases and percentage by Chi-square test. Measurement data conforming to the normal distribution were expressed as the mean&#x2009;&#x00B1;&#x2009;standard deviation, and the comparison between two groups was performed by t-test; non-normally distributed measurements were expressed as the median (interquartile range), and the comparison between two groups was performed by the Mann&#x2013;Whitney U test. <italic>P</italic>&#x2009;&#x003C;&#x2009;0.05 was considered as statistically significant difference. Data from this retrospective clinical analysis.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3b"><title>Comparison of nutritional status indexes (ALB, Hb, GNRI) in two groups of elderly CHF patients</title>
<p>We compared the nutritional status indexes (ALB, Hb, GNRI) of two groups of elderly CHF patients. The results showed that the levels of ALB, Hb, and GNRI were significantly decreased in elderly CHF patients in the poor prognosis group compared to patients in the good prognosis group (<italic>P</italic>&#x2009;&#x003C;&#x2009;0.001) (<xref ref-type="fig" rid="F1">Figures&#x00A0;1A,B</xref>). The above results indicated that there was a significant reduction in nutritional status in elderly patients with poor prognosis of CHF.</p>
<fig id="F1" position="float"><label>Figure&#x00A0;1</label>
<caption><p>Comparison of nutritional status indexes (ALB, Hb, GNRI) between two groups of elderly CHF patients. <bold>(A,B)</bold> Laboratory examination of ALB and Hb levels; <bold>(C)</bold> Assessment of the nutritional status of the patients according to the GNRI formula, GNRI&#x2009;&#x003D;&#x2009;1.489&#x2009;&#x00D7;&#x2009;serum albumin (g/L)&#x2009;&#x002B;&#x2009;41.7&#x2009;&#x00D7;&#x2009;actual weight (kg)/ideal weight. The graphs conform to the normal distribution and are expressed as mean&#x2009;&#x00B1;&#x2009;standard deviation using the independent samples <italic>t</italic>-test. &#x002A;&#x002A;&#x002A; indicates <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001. Source: Data from this retrospective study. Figures were generated using GraphPad Prism 9.5.0.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-13-1736628-g001.tif"><alt-text content-type="machine-generated">Three scatter plots labeled A, B, and C compare two groups, &#x201C;Good prognosis (n=142)&#x201D; and &#x201C;Poor prognosis (n=48)&#x201D; for ALB, Hb, and GNRI. All plots show significantly higher values in the good prognosis group, marked by three asterisks above each comparison.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c"><title>Different cardiac function classifications nutritional status indexes (ALB, Hb, GNRI) levels in elderly CHF patients</title>
<p>We compared the levels of nutritional status indexes (ALB, Hb, GNRI) in elderly CHF patients with different cardiac function classifications, and found that the levels of ALB, Hb, and GNRI gradually decreased in elderly CHF patients as NYHA cardiac function classifications increased (all <italic>P</italic>&#x2009;&#x003C;&#x2009;0.01) (<xref ref-type="fig" rid="F2">Figures&#x00A0;2A&#x2013;C</xref>). In addition, we further analyzed the correlation between the levels of nutritional status indexes (ALB, Hb, GNRI) and NYHA cardiac function grading in elderly CHF patients, and Spearman&#x0027;s correlation analysis showed that the levels of ALB, Hb, and GNRI were significantly negatively correlated with NYHA cardiac function grading in elderly CHF patients, respectively (<italic>P</italic>&#x2009;&#x003C;&#x2009;0.001, r&#x2009;&#x003D;&#x2009;&#x2212;0.518; <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001, r&#x2009;&#x003D;&#x2009;&#x2212;0.436; <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001, r&#x2009;&#x003D;&#x2009;&#x2212;0.571) (<xref ref-type="fig" rid="F2">Figures&#x00A0;2D&#x2013;F</xref>). These results suggest that the worse the cardiac function, the worse the nutritional status of elderly CHF patients.</p>
<fig id="F2" position="float"><label>Figure&#x00A0;2</label>
<caption><p>Levels of nutritional status indexes (ALB, Hb, GNRI) in elderly CHF patients with different cardiac function classifications. <bold>(A,B)</bold> Laboratory examination of serum ALB and Hb levels; <bold>(C)</bold> Nutritional status of the patients was evaluated according to the GNRI formula,GNRI&#x2009;&#x003D;&#x2009;1.489&#x2009;&#x00D7;&#x2009;serum albumin (g/L)&#x2009;&#x002B;&#x2009;41.7&#x2009;&#x00D7;&#x2009;actual weight (kg)/ideal weight; <bold>(D-F)</bold> Spearman&#x0027;s correlation coefficient to analyze the correlation between ALB, Hb, GNRI and NYHA cardiac function grading of the elderly CHF patients. r is the correlation coefficient. <italic>r</italic> is the correlation coefficient. Normal distribution was conformed in <bold>(A&#x2013;C)</bold>, expressed as mean&#x2009;&#x00B1;&#x2009;standard deviation, and analyzed by one-way ANOVA. &#x002A;&#x002A; indicates <italic>P</italic>&#x2009;&#x003C;&#x2009;0.01 and &#x002A;&#x002A;&#x002A; indicates <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001. Source: Data from this retrospective study. Figures were generated using GraphPad Prism 9.5.0.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-13-1736628-g002.tif"><alt-text content-type="machine-generated">Panel A is a scatter plot comparing albumin (ALB) levels across NYHA II, III, and IV groups with significant differences indicated. Panel B is a scatter plot comparing hemoglobin (Hb) levels across the same NYHA groups with significant differences. Panel C shows GNRI measured across NYHA groups with marked statistical significance. Panel D shows a negative correlation between NYHA class and ALB. Panel E depicts a negative correlation between NYHA class and Hb. Panel F presents a negative correlation between NYHA class and GNRI. Each plot contains statistical significance and correlation coefficients.\n</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3d"><title>Low expression of ALB, Hb, and GNRI significantly increases the incidence of poor prognosis in elderly CHF patients</title>
<p>In order to further investigate the relationship between nutritional status indexes (ALB, Hb, GNRI) and the prognosis of elderly CHF patients, the median values of ALB level (36.40), Hb level (126), and GNRI level (90.96) of elderly CHF patients were used as the cut-off values, and the elderly CHF patients were categorized into the ALB high-low-expression group, Hb high-low-expression group, and GNRI high-low-expression group, and compared the incidence of poor prognosis of elderly CHF patients in the two groups, and the results showed that the incidence of poor prognosis of patients in the low -ALB group, the low -Hb group, and the low -GNRI group was 83.33&#x0025;, 85.42&#x0025;, and 91.67&#x0025;, respectively, which was significantly higher than that of the high -ALB group (16.67&#x0025;), the high-Hb group (14.58&#x0025;) and the high-GNRI group (8.5&#x0025;) (all <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001) (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>). Subsequently, poor prognostic Kaplan&#x2013;Meier curves of elderly CHF patients were plotted based on Kaplan&#x2013;Meier curves and log-rank test (log-rank) distribution comparison, and the results showed that the KM curve of patients with low expression of ALB, Hb and GNRI shifted to the left compared with those with high expression of ALB, Hb and GNRI. That is, the poor prognosis rate of elderly CHF patients with low expression of ALB, Hb and GNRI was significantly reduced (all <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001) (<xref ref-type="fig" rid="F3">Figures&#x00A0;3A,B</xref>). The above results indicate suggest that low expression of ALB, Hb, and GNRI significantly increases the risk of poor prognosis in elderly CHF patients.</p>
<table-wrap id="T2" position="float"><label>Table&#x00A0;2</label>
<caption><p>The relationship between the levels of ALB, Hb and GNRI and the prognosis of elderly patients with CHF.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Group</th>
<th valign="top" align="center">Good prognosis</th>
<th valign="top" align="center">Poor prognosis</th>
<th valign="top" align="center">&#x03C7;2</th>
<th valign="top" align="center"><italic>P</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Low-ALB (<italic>n</italic>&#x2009;&#x003D;&#x2009;95)</td>
<td valign="top" align="center">55 (38.73&#x0025;)</td>
<td valign="top" align="center">40 (83.33&#x0025;)</td>
<td valign="top" align="center" rowspan="2">28.541</td>
<td valign="top" align="center" rowspan="2">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">High-ALB (<italic>n</italic>&#x2009;&#x003D;&#x2009;95)</td>
<td valign="top" align="center">87 (61.27&#x0025;)</td>
<td valign="top" align="center">8 (16.67&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Low- Hb (<italic>n</italic>&#x2009;&#x003D;&#x2009;95)</td>
<td valign="top" align="center">54 (38.03&#x0025;)</td>
<td valign="top" align="center">41 (85.42&#x0025;)</td>
<td valign="top" align="center" rowspan="2">32.221</td>
<td valign="top" align="center" rowspan="2">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">High-Hb (<italic>n</italic>&#x2009;&#x003D;&#x2009;95)</td>
<td valign="top" align="center">88 (61.97&#x0025;)</td>
<td valign="top" align="center">7 (14.58&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Low- GNRI (<italic>n</italic>&#x2009;&#x003D;&#x2009;95)</td>
<td valign="top" align="center">51 (35.92&#x0025;)</td>
<td valign="top" align="center">44 (91.67&#x0025;)</td>
<td valign="top" align="center" rowspan="2">44.601</td>
<td valign="top" align="center" rowspan="2">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">High-GNRI (<italic>n</italic>&#x2009;&#x003D;&#x2009;95)</td>
<td valign="top" align="center">91 (64.08&#x0025;)</td>
<td valign="top" align="center">4 (8.33&#x0025;)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TF2"><p>Count data were expressed using the number of cases and percentages, and differences were considered statistically significant using the Chi-square test <italic>P</italic>&#x2009;&#x003C;&#x2009;0.05. Data from this retrospective clinical analysis.</p></fn>
</table-wrap-foot>
</table-wrap>
<fig id="F3" position="float"><label>Figure&#x00A0;3</label>
<caption><p>Poor prognostic curve of elderly CHF patients with different levels of nutritional status indexes (ALB, Hb, GNRI). <bold>(A&#x2013;C)</bold> Log-rank analysis to plot poor prognostic curves in elderly CHF patients with ALB, Hb, and GNRI levels. Source: Data from this retrospective study. Figures were generated using GraphPad Prism 9.5.0.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-13-1736628-g003.tif"><alt-text content-type="machine-generated">Three Kaplan-Meier survival curves labeled A, B, and C compare probability of poor prognosis over twelve months for two groups each: low (blue) versus high (red) levels of ALB, Hb, and GNRI, respectively. In all panels, the high-level groups demonstrate lower probabilities of poor prognosis compared to low-level groups, and each comparison has P-value less than 0.001.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3e"><title>Univariate and multivariate cox regression analysis of prognostic factors in elderly patients with CHF</title>
<p>Using the follow-up time as the time variable and the prognosis of elderly CHF patients as the dependent variable (good prognosis&#x2009;&#x003D;&#x2009;0, poor prognosis&#x2009;&#x003D;&#x2009;1), the pathological baseline characteristics of the population enrolled in <xref ref-type="table" rid="T1">Table&#x00A0;1</xref> age, gender, smoking history, drinking history, hypertension, hyperlipidemia, diabetes, LAD, LVDs, LVDd, LVEF, hs-CRP, NT-proBNP, NYHA cardiac function Classification and ALB, Hb, and GNRI were taken as independent variables for univariate analysis, which showed that LVDs, LVDd, LVEF, hs-CRP, NT-proBNP, NYHA cardiac function classification, ALB, Hb, and GNRI were significantly correlated with the prognostic status of elderly patients with CHF (all <italic>P</italic>&#x2009;&#x003C;&#x2009;0.05, <xref ref-type="table" rid="T3">Table&#x00A0;3</xref>); Subsequently, the variables with statistically significant differences in the univariate Cox regression analysis were included in the multivariate Cox regression model. The results showed that the multivariate results indicated that LVEF, NT-proBNP, NYHA cardiac function classification, ALB, Hb, and GNRI were independent prognostic factors affecting elderly CHF patients (all <italic>P</italic>&#x2009;&#x003C;&#x2009;0.05, <xref ref-type="table" rid="T3">Table&#x00A0;3</xref>).</p>
<table-wrap id="T3" position="float"><label>Table&#x00A0;3</label>
<caption><p>Univariate and multivariate Cox regression analysis of prognostic factors in elderly patients with CHF.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" rowspan="2">Variable</th>
<th valign="top" align="center" colspan="2">Univariable</th>
<th valign="top" align="center" colspan="2">Multivariable</th>
</tr>
<tr>
<th valign="top" align="center">HR (95&#x0025; CI)</th>
<th valign="top" align="center"><italic>P</italic></th>
<th valign="top" align="center">HR (95&#x0025; CI)</th>
<th valign="top" align="center"><italic>P</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age (years)</td>
<td valign="top" align="center">1.051 (0.971&#x2013;1.138)</td>
<td valign="top" align="center">0.218</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">/</td>
</tr>
<tr>
<td valign="top" align="left">Gender (<italic>n</italic>, &#x0025;)</td>
<td valign="top" align="center">1.194 (0.670&#x2013;2.130)</td>
<td valign="top" align="center">0.548</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">/</td>
</tr>
<tr>
<td valign="top" align="left">Smoking history (<italic>n</italic>, &#x0025;)</td>
<td valign="top" align="center">1.046 (0.592&#x2013;1.851)</td>
<td valign="top" align="center">0.876</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">/</td>
</tr>
<tr>
<td valign="top" align="left">Drinking history (<italic>n</italic>, &#x0025;)</td>
<td valign="top" align="center">1.085 (0.605&#x2013;1.947)</td>
<td valign="top" align="center">0.784</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Hypertension (<italic>n</italic>, &#x0025;)</td>
<td valign="top" align="center">1.104 (0.626&#x2013;1.944)</td>
<td valign="top" align="center">0.733</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">/</td>
</tr>
<tr>
<td valign="top" align="left">Hyperlipidemia (<italic>n</italic>, &#x0025;)</td>
<td valign="top" align="center">1.182 (0.654&#x2013;2.136)</td>
<td valign="top" align="center">0.579</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">/</td>
</tr>
<tr>
<td valign="top" align="left">Diabetes (<italic>n</italic>, &#x0025;)</td>
<td valign="top" align="center">1.121 (0.503&#x2013;2.498)</td>
<td valign="top" align="center">0.780</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">/</td>
</tr>
<tr>
<td valign="top" align="left">LAD (mm)</td>
<td valign="top" align="center">1.050 (0.844&#x2013;1.306)</td>
<td valign="top" align="center">0.663</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">/</td>
</tr>
<tr>
<td valign="top" align="left">LVDs (mm)</td>
<td valign="top" align="center">1.743 (1.483&#x2013;2.050)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.007 (0.833&#x2013;1.218)</td>
<td valign="top" align="center">0.944</td>
</tr>
<tr>
<td valign="top" align="left">LVDd (mm)</td>
<td valign="top" align="center">1.913 (1.648&#x2013;2.220)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.043 (0.844&#x2013;1.290)</td>
<td valign="top" align="center">0.695</td>
</tr>
<tr>
<td valign="top" align="left">LVEF (&#x0025;)</td>
<td valign="top" align="center">0.858 (0.794&#x2013;0.927)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.114 (1.003&#x2013;1.238)</td>
<td valign="top" align="center">0.045</td>
</tr>
<tr>
<td valign="top" align="left">hs-CRP (mg/L)</td>
<td valign="top" align="center">2.710 (2.092&#x2013;3.511)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.118 (0.829&#x2013;1.508)</td>
<td valign="top" align="center">0.466</td>
</tr>
<tr>
<td valign="top" align="left">NT-proBNP (ng/L)</td>
<td valign="top" align="center">1.019 (1.015&#x2013;1.023)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.013 (1.007&#x2013;1.019)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">NYHA cardiac function classification</td>
<td valign="top" align="center">7.470 (4.496&#x2013;12.411)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">2.220 (1.188&#x2013;4.148)</td>
<td valign="top" align="center">0.012</td>
</tr>
<tr>
<td valign="top" align="left">ALB (g/L)</td>
<td valign="top" align="center">0.761 (0.704&#x2013;0.823)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.279 (1.052&#x2013;1.555)</td>
<td valign="top" align="center">0.014</td>
</tr>
<tr>
<td valign="top" align="left">Hb (g/L)</td>
<td valign="top" align="center">0.751 (0.699&#x2013;0.807)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.872 (0.792&#x2013;0.960)</td>
<td valign="top" align="center">0.005</td>
</tr>
<tr>
<td valign="top" align="left">GNRI</td>
<td valign="top" align="center">0.835 (0.799&#x2013;0.873)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.853 (0.756&#x2013;0.962)</td>
<td valign="top" align="center">0.010</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TF3"><p>Data from this retrospective clinical analysis.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3f"><title>Analysis of the value of ALB, Hb, and GNRI in predicting poor prognosis in elderly patients with CHF</title>
<p>Based on these results, we used ROC curve analysis to further assess the predictive value of ALB, Hb, and GNRI for poor prognosis in elderly CHF patients. The results showed that the area under the ROC curve (AUC) of ALB for predicting poor prognosis in elderly CHF patients was 0.845, with a sensitivity of 72.92&#x0025;, a specificity of 79.58&#x0025;, and a cutoff value of 35.05; the AUC of Hb for predicting poor prognosis in elderly CHF patients was 0.884, with a sensitivity of 77.08&#x0025;, a specificity of 79.58&#x0025;, with a cutoff value of 124.50; GNRI predicted poor prognosis in elderly CHF patients with an AUC of 0.896, a sensitivity of 81.25&#x0025;, specificity was 80.99&#x0025; and cutoff value was 88.56 (<xref ref-type="fig" rid="F4">Figures&#x00A0;4A&#x2013;C</xref>). The above results suggest that nutritional status indexes (ALB, Hb, GNRI) has a good predictive value for poor prognosis in elderly CHF patients.</p>
<fig id="F4" position="float"><label>Figure&#x00A0;4</label>
<caption><p>Analysis of the value of ALB, Hb, and GNRI in predicting poor prognosis in elderly patients with CHF. <bold>(A&#x2013;C)</bold> ROC curve analysis of ALB, Hb, and GNRI in elderly patients with CHF. Source: Data from this retrospective study. Figures were generated using GraphPad Prism 9.5.0.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-13-1736628-g004.tif"><alt-text content-type="machine-generated">Three ROC curve graphs compare ALB, Hb, and GNRI for diagnostic performance, with area under the curve values of zero point eight four five, zero point eight eight four, and zero point eight nine six respectively, all with p-values less than zero point zero zero zero one.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><title>Discussion</title>
<p>Chronic heart failure is a group of syndromes occurring in the decompensated phase of end-stage heart disease, and is prevalent in the elderly. As the main group of chronic heart failure, the elderly have nutritional and metabolic disturbances &#x2014; such as multimorbidity, multiple organ disease, diarrhea, and bloating, which can trigger acute exacerbation of CHF, worsen the clinical course, and increase the morbidity, mortality, and readmission rates (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). Malnutrition is defined as insufficient, excessive or imbalanced intake of energy and/or nutrients. As malnutrition worsens in elderly patients with CHF, the reduction in muscle mass and loss of muscle function can further lead to cardiac cachexia, which enters into a vicious cycle of &#x201C;malnutrition-cachexia&#x201D;, aggravating fluid retention and inflammation, ultimately leading to a poor prognosis (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). Timely and effective nutritional risk assessment and supportive interventions can improve the prognosis of elderly patients with CHF.</p>
<p>In this study, we found that ALB, Hb and GNRI levels were significantly lower in the poor prognosis group compared to the good prognosis group. This result is consistent with previous studies, suggesting that malnutrition may play an important role in the poor prognosis of elderly CHF patients. Malnutrition can lead to muscle atrophy, decreased immune function and impaired organ function, which in turn affects the recovery and maintenance of cardiac function and increases re-hospitalization and mortality (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B27">27</xref>). Furthermore, ALB, Hb and GNRI levels declined progressively with higher NYHA class and showed significant negative correlations with cardiac function grade. This suggests that the worse the cardiac function, the worse the nutritional status of the patients, suggesting that deteriorating nutritional status may exacerbate cardiac impairment. The possible mechanism is that ALB is a plasma protein synthesized by the liver with important functions such as maintaining plasma colloid osmotic pressure and transporting substances (<xref ref-type="bibr" rid="B28">28</xref>). Patients with severe cardiac insufficiency are often accompanied by gastrointestinal stasis, leading to digestive and absorption dysfunction, which in turn causes insufficient nutrient intake and malabsorption (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). Meanwhile, heart failure is characterized by low-grade inflammation, a common feature of chronic disease progression, leading to the destruction of body composition, making serum ALB levels lower and further exacerbating malnutrition (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Reduced levels of Hb are more common in elderly patients with CHF, and anemia can lead to an increase in the heart&#x0027;s compensatory workload, exacerbating the heart&#x0027;s burden, as well as affecting the myocardium&#x0027;s oxygen supply and promote myocardial remodeling, leading to worsening heart failure (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B32">32</xref>). In addition, GNRI integrates information on body weight and ALB, provides a more comprehensive nutritional assessment; its decline may indicate loss of muscle mass and protein imbalance, common in elderly CHF patients (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>).</p>
<p>ROC analysis revealed that ALB, Hb and GNRI had high predictive values for poor prognosis in elderly CHF patients, with AUCs of 0.845, 0.884 and 0.896, respectively. Among them, the predictive value of GNRI was the highest, which may be related to its combined consideration of serum albumin level and body weight (<xref ref-type="bibr" rid="B35">35</xref>). As a simple, non-invasive nutritional index requiring no additional tests, GNRI holds practical utility in clinical practice (<xref ref-type="bibr" rid="B36">36</xref>). Kaplan&#x2013;Meier survival analysis showed that patients with low ALB, Hb, or GNRI had significantly poorer outcomes, further underscoring the close link between nutrition and prognosis (<xref ref-type="bibr" rid="B34">34</xref>). Cox regression analysis showed that ALB, Hb and GNRI were independent influences on the prognosis of elderly CHF patients, which implies that in addition to the traditional clinical indexes such as LVEF, NT-proBNP and NYHA cardiac function classification, nutritional status indexes are also important in the assessment of patient prognosis. grading, indicators of nutritional status should also be taken into consideration (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B37">37</xref>).</p>
<p>This study offers new insights for the clinical management of elderly CHF patients. First, in clinical practice, attention should be paid to assessing the nutritional status of elderly patients with CHF, and ALB and Hb levels should be tested and GNRI should be calculated regularly in order to detect malnourished patients in a timely manner. Second, for malnourished patients, individualized nutritional support programs, including dietary guidance and necessary nutritional supplementation, should be developed to improve the nutritional status and prognosis of patients. In addition, nutritional status indicators can be used as an important supplement to the prognostic assessment of elderly CHF patients, which can help clinicians more accurately predict the prognosis of patients and formulate more reasonable treatment strategies.</p>
<p>This study has several limitations that should be acknowledged. First, it was a single-center retrospective study with a relatively small sample size, which may introduce selection bias and limit the generalizability of our findings. Second, the results have not been validated in an independent external cohort, which is necessary to confirm their reproducibility and clinical applicability. Third, although ROC analysis was used to evaluate the predictive performance of individual nutritional indices, this study did not develop a combined predictive model. Future studies constructing prognostic models could consider incorporating more comprehensive performance metrics such as the Matthews correlation coefficient (MCC) or F1 score to provide a more robust evaluation of model classification ability. Fourth, this study included predominantly HFmrEF and HFpEF patients, with very few HFrEF cases (<italic>n</italic>&#x2009;&#x003D;&#x2009;3). Consequently, we were unable to conduct meaningful stratified analyses across all three HF subtypes based on LVEF classification. Future multi-center studies with balanced representation of HFrEF, HFmrEF, and HFpEF patients are warranted to clarify potential differences in nutritional status and its prognostic implications among distinct heart failure phenotypes. Fifth, this study did not systematically collect data on patients&#x2019; socioeconomic status (e.g., education, income, social support) or psychiatric comorbidities (e.g., depression, anxiety), which are known to influence nutritional intake, self-care behaviors, and clinical outcomes in heart failure. The absence of these variables limits our ability to fully elucidate the multifactorial etiology of malnutrition in this population. Sixth, the follow-up period was limited to one year; a longer observation window (e.g., two years or more) would allow for a more comprehensive assessment of rehospitalization patterns and long-term prognostic determinants. Finally, due to the retrospective design, a prospective sample size calculation was not performed. Although a <italic>post-hoc</italic> power analysis suggested adequate statistical power with the current cohort, the absence of <italic>a priori</italic> sample size estimation may affect the robustness and reproducibility of the results. Future studies should expand the sample size and adopt a multicenter prospective design to validate our findings and further elucidate the specific mechanisms through which malnutrition influences prognosis in elderly CHF patients. Additionally, future prospective studies should incorporate these psychosocial and socioeconomic dimensions, along with extended follow-up, to provide a more holistic understanding of the determinants and consequences of malnutrition in elderly patients with CHF.</p>
<p>In conclusion, this study confirms that nutritional status indexes (ALB, Hb, GNRI) are closely related to the prognosis of elderly patients with CHF and has a good predictive value of poor prognosis for patients. Clinicians should pay attention to the assessment of nutritional status in elderly CHF patients and incorporate it into the prognostic assessment system in order to develop a more optimal treatment plan and improve the clinical outcomes of patients.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability"><title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement"><title>Ethics statement</title>
<p>All subjects participating in the study were informed of the purpose of the study and signed an informed consent form, which was reviewed and approved by the Ethics Committee of Xian Peoples Hospital (Xian Fourth Hospital) in accordance with the Declaration of Helsinki.</p>
</sec>
<sec id="s7" sec-type="author-contributions"><title>Author contributions</title>
<p>MX: Investigation, Writing &#x2013; original draft, Formal analysis, Visualization, Resources, Validation, Supervision, Data curation, Methodology, Writing &#x2013; review &#x0026; editing, Conceptualization. CW: Writing &#x2013; original draft, Data curation, Methodology, Project administration, Investigation, Visualization, Writing &#x2013; review &#x0026; editing. LW: Validation, Writing &#x2013; review &#x0026; editing, Project administration, Supervision, Investigation, Writing &#x2013; original draft, Formal analysis. JG: Investigation, Writing &#x2013; original draft, Resources, Validation, Writing &#x2013; review &#x0026; editing, Data curation, Supervision. YZ: Resources, Validation, Data curation, Project administration, Conceptualization, Visualization, Writing &#x2013; review &#x0026; editing, Supervision, Methodology, Investigation, Writing &#x2013; original draft.</p>
</sec>
<sec id="s9" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s11" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>K</given-names></name> <name><surname>Zeng</surname> <given-names>WJ</given-names></name> <name><surname>Hu</surname> <given-names>ZH.</given-names></name></person-group> <article-title>Expression and clinical implications of pro-BNP and soluble ST2 in chronic heart failure</article-title>. <source>Br J Hosp Med Lond Engl</source>. (<year>2024</year>) <volume>85</volume>(<issue>12</issue>):<fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.12968/hmed.2024.0465</pub-id></mixed-citation></ref>
<ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coats</surname> <given-names>AJS</given-names></name></person-group>. <article-title>Ageing, demographics, and heart failure</article-title>. <source>Eur Heart J Suppl J Eur Soc Cardiol</source>. (<year>2019</year>) <volume>21</volume>(<issue>Suppl L</issue>):<fpage>L4</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/suz235</pub-id></mixed-citation></ref>
<ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omote</surname> <given-names>K</given-names></name> <name><surname>Verbrugge</surname> <given-names>FH</given-names></name> <name><surname>Borlaug</surname> <given-names>BA</given-names></name></person-group>. <article-title>Heart failure with preserved ejection fraction: mechanisms and treatment strategies</article-title>. <source>Annu Rev Med</source>. (<year>2022</year>) <volume>73</volume>:<fpage>321</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-med-042220-022745</pub-id><pub-id pub-id-type="pmid">34379445</pub-id></mixed-citation></ref>
<ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosy</surname> <given-names>AP</given-names></name> <name><surname>Fonarow</surname> <given-names>GC</given-names></name> <name><surname>Butler</surname> <given-names>J</given-names></name> <name><surname>Chioncel</surname> <given-names>O</given-names></name> <name><surname>Greenen</surname> <given-names>SJ</given-names></name> <name><surname>Vaduganathan</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized <italic>The global health and economic burden of hospitalizations for</italic> heart failure: lessons learned from hospitalized heart failure registries</article-title>. <source>J Am Coll Cardiol</source>. (<year>2014</year>) <volume>63</volume>(<issue>12</issue>):<fpage>1123</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2013.11.053</pub-id><pub-id pub-id-type="pmid">24491689</pub-id></mixed-citation></ref>
<ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savarese</surname> <given-names>G</given-names></name> <name><surname>Becher</surname> <given-names>PM</given-names></name> <name><surname>Lund</surname> <given-names>LH</given-names></name> <name><surname>Seferovic</surname> <given-names>P</given-names></name> <name><surname>Rosano</surname> <given-names>GMC</given-names></name> <name><surname>Coats</surname> <given-names>AJS.</given-names></name></person-group> <article-title>Global burden of heart failure: a comprehensive and updated review of epidemiology</article-title>. <source>Cardiovasc Res</source>. (<year>2023</year>) <volume>118</volume>(<issue>17</issue>):<fpage>3272</fpage>&#x2013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvac013</pub-id><pub-id pub-id-type="pmid">35150240</pub-id></mixed-citation></ref>
<ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname> <given-names>K</given-names></name> <name><surname>Ha&#x00DF;</surname> <given-names>U</given-names></name> <name><surname>Pirlich</surname> <given-names>M</given-names></name></person-group>. <article-title>Malnutrition in older adults-recent advances and remaining challenges</article-title>. <source>Nutrients</source>. (<year>2021</year>) <volume>13</volume>(<issue>8</issue>):<fpage>2764</fpage>. <pub-id pub-id-type="doi">10.3390/nu13082764</pub-id><pub-id pub-id-type="pmid">34444924</pub-id></mixed-citation></ref>
<ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname> <given-names>T</given-names></name> <name><surname>Haboubi</surname> <given-names>N</given-names></name></person-group>. <article-title>Assessment and management of nutrition in older people and its importance to health</article-title>. <source>Clin Interv Aging</source>. (<year>2010</year>) <volume>5</volume>:<fpage>207</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.2147/cia.s9664</pub-id><pub-id pub-id-type="pmid">20711440</pub-id></mixed-citation></ref>
<ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hersberger</surname> <given-names>L</given-names></name> <name><surname>Dietz</surname> <given-names>A</given-names></name> <name><surname>B&#x00FC;rgler</surname> <given-names>H</given-names></name> <name><surname>Bargetzi</surname> <given-names>A</given-names></name> <name><surname>Bargetzi</surname> <given-names>L</given-names></name> <name><surname>Braun</surname> <given-names>NK.</given-names></name></person-group> <article-title>Individualized nutritional support for hospitalized patients with chronic heart failure</article-title>. <source>J Am Coll Cardiol</source>. (<year>2021</year>) <volume>77</volume>(<issue>18</issue>):<fpage>2307</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2021.03.232</pub-id><pub-id pub-id-type="pmid">33958128</pub-id></mixed-citation></ref>
<ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wleklik</surname> <given-names>M</given-names></name> <name><surname>Uchmanowicz</surname> <given-names>I</given-names></name> <name><surname>Jankowska-Pola&#x0144;ska</surname> <given-names>B</given-names></name> <name><surname>Andreae</surname> <given-names>C</given-names></name> <name><surname>Regulska-Ilow</surname> <given-names>B.</given-names></name></person-group> <article-title>The role of nutritional status in elderly patients with heart failure</article-title>. <source>J Nutr Health Aging</source>. (<year>2018</year>) <volume>22</volume>(<issue>5</issue>):<fpage>581</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s12603-017-0985-1</pub-id><pub-id pub-id-type="pmid">29717757</pub-id></mixed-citation></ref>
<ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sze</surname> <given-names>S</given-names></name> <name><surname>Pellicori</surname> <given-names>P</given-names></name> <name><surname>Kazmi</surname> <given-names>S</given-names></name> <name><surname>Rigby</surname> <given-names>A</given-names></name> <name><surname>Cleland John</surname> <given-names>GF</given-names></name> <name><surname>Wong</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Prevalence and prognostic significance of malnutrition using 3 scoring systems among outpatients with heart failure. A comparison with body mass Index</article-title>. <source>JACC Heart Fail</source>. (<year>2018</year>) <volume>6</volume>(<issue>6</issue>):<fpage>476</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchf.2018.02.018</pub-id><pub-id pub-id-type="pmid">29753673</pub-id></mixed-citation></ref>
<ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zainul</surname> <given-names>O</given-names></name> <name><surname>Perry</surname> <given-names>D</given-names></name> <name><surname>Pan</surname> <given-names>M</given-names></name> <name><surname>Lau</surname> <given-names>J</given-names></name> <name><surname>Zarzuela</surname> <given-names>K</given-names></name> <name><surname>Kim</surname> <given-names>R</given-names></name><etal/></person-group> <article-title>Malnutrition in heart failure with preserved ejection fraction</article-title>. <source>J Am Geriatr Soc</source>. (<year>2023</year>) <volume>71</volume>(<issue>11</issue>):<fpage>3367</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1111/jgs.18590</pub-id><pub-id pub-id-type="pmid">37706670</pub-id></mixed-citation></ref>
<ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname> <given-names>JS</given-names></name> <name><surname>Magno</surname> <given-names>CP</given-names></name> <name><surname>Lane</surname> <given-names>KT</given-names></name> <name><surname>Chan</surname> <given-names>T</given-names></name> <name><surname>Hoyt</surname> <given-names>DB</given-names></name> <name><surname>Greenfield</surname> <given-names>S.</given-names></name></person-group> <article-title>Nutrition impacts the prevalence of peripheral arterial disease in the United States</article-title>. <source>J Vasc Surg</source>. (<year>2008</year>) <volume>48</volume>(<issue>4</issue>):<fpage>897</fpage>&#x2013;<lpage>904</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvs.2008.05.014</pub-id><pub-id pub-id-type="pmid">18586439</pub-id></mixed-citation></ref>
<ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>T</given-names></name> <name><surname>Jiang</surname> <given-names>Y</given-names></name> <name><surname>Jin</surname> <given-names>Q</given-names></name> <name><surname>Xu</surname> <given-names>SN</given-names></name> <name><surname>Fingerhut</surname> <given-names>A</given-names></name> <name><surname>Shi</surname> <given-names>YS</given-names></name><etal/></person-group> <article-title>Role of perioperative nutritional status and enteral nutrition in predicting and preventing post-operative complications in patients with Crohn&#x2019;s disease. Role of perioperative nutritional status and enteral nutrition in predicting and preventing post-operative complications in patients with crohn&#x2019;s disease</article-title>. <source>Front Nutr</source>. (<year>2022</year>) <volume>9</volume>:<fpage>1085037</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2022.1085037</pub-id><pub-id pub-id-type="pmid">36687711</pub-id></mixed-citation></ref>
<ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>A</given-names></name> <name><surname>Wu</surname> <given-names>L</given-names></name> <name><surname>Lin</surname> <given-names>L</given-names></name> <name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Liao</surname> <given-names>X</given-names></name> <name><surname>Chen</surname> <given-names>L</given-names></name><etal/></person-group> <article-title>The geriatric nutritional risk index is related to adverse hospitalization outcomes in individuals undergoing cardiac surgery</article-title>. <source>Sci Rep</source>. (<year>2024</year>) <volume>14</volume>(<issue>1</issue>):<fpage>19126</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-024-69668-x</pub-id><pub-id pub-id-type="pmid">39155300</pub-id></mixed-citation></ref>
<ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armentaro</surname> <given-names>G</given-names></name> <name><surname>Condoleo</surname> <given-names>V</given-names></name> <name><surname>Pastura</surname> <given-names>CA</given-names></name> <name><surname>Grasso</surname> <given-names>M</given-names></name> <name><surname>Frasca</surname> <given-names>A</given-names></name> <name><surname>Martire</surname> <given-names>D</given-names></name><etal/></person-group> <article-title>Prognostic role of serum albumin levels in patients with chronic heart failure</article-title>. <source>Intern Emerg Med</source>. (<year>2024</year>) <volume>19</volume>(<issue>5</issue>):<fpage>1323</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1007/s11739-024-03612-9</pub-id><pub-id pub-id-type="pmid">38776047</pub-id></mixed-citation></ref>
<ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiyovich</surname> <given-names>A</given-names></name> <name><surname>Bental</surname> <given-names>T</given-names></name> <name><surname>Assali</surname> <given-names>A</given-names></name> <name><surname>Vaknin-Assa</surname> <given-names>H</given-names></name> <name><surname>Kornowski</surname> <given-names>R</given-names></name> <name><surname>Perl</surname> <given-names>L.</given-names></name></person-group> <article-title>Changes over time in serum albumin levels predict outcomes following percutaneous coronary intervention</article-title>. <source>J Cardiol</source>. (<year>2020</year>) <volume>75</volume>(<issue>4</issue>):<fpage>381</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.jjcc.2019.08.019</pub-id><pub-id pub-id-type="pmid">31547947</pub-id></mixed-citation></ref>
<ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alnuwaysir</surname> <given-names>RIS</given-names></name> <name><surname>Hoes</surname> <given-names>MF</given-names></name> <name><surname>van Veldhuisen</surname> <given-names>DJ</given-names></name> <name><surname>Meer</surname> <given-names>PV</given-names></name> <name><surname>Beverborg</surname> <given-names>NG.</given-names></name></person-group> <article-title>Iron deficiency in heart failure: mechanisms and pathophysiology</article-title>. <source>J Clin Med</source>. (<year>2021</year>) <volume>11</volume>(<issue>1</issue>):<fpage>125</fpage>. <pub-id pub-id-type="doi">10.3390/jcm11010125</pub-id><pub-id pub-id-type="pmid">35011874</pub-id></mixed-citation></ref>
<ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname> <given-names>IS</given-names></name> <name><surname>Gupta</surname> <given-names>P</given-names></name></person-group>. <article-title>Anemia and iron deficiency in heart failure: current concepts and emerging therapies</article-title>. <source>Circulation</source>. (<year>2018</year>) <volume>138</volume>(<issue>1</issue>):<fpage>80</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.030099</pub-id><pub-id pub-id-type="pmid">29967232</pub-id></mixed-citation></ref>
<ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouillanne</surname> <given-names>O</given-names></name> <name><surname>Morineau</surname> <given-names>G</given-names></name> <name><surname>Dupont</surname> <given-names>C</given-names></name> <name><surname>Coulombel</surname> <given-names>I</given-names></name> <name><surname>Vincent</surname> <given-names>JP</given-names></name> <name><surname>Nicolis</surname> <given-names>I</given-names></name><etal/></person-group> <article-title>Geriatric nutritional risk Index: a new index for evaluating at-risk elderly medical patients</article-title>. <source>Am J Clin Nutr</source>. (<year>2005</year>) <volume>82</volume>(<issue>4</issue>):<fpage>777</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/82.4.777</pub-id><pub-id pub-id-type="pmid">16210706</pub-id></mixed-citation></ref>
<ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>Y</given-names></name> <name><surname>Lin</surname> <given-names>T</given-names></name> <name><surname>Hou</surname> <given-names>L</given-names></name> <name><surname>Zhang</surname> <given-names>M</given-names></name> <name><surname>Peng</surname> <given-names>X</given-names></name> <name><surname>Xie</surname> <given-names>DM</given-names></name><etal/></person-group> <article-title>Association between geriatric nutritional risk Index and frailty in older hospitalized patients</article-title>. <source>Clin Interv Aging</source>. (<year>2021</year>) <volume>16</volume>:<fpage>1241</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.2147/CIA.S313827</pub-id><pub-id pub-id-type="pmid">34234424</pub-id></mixed-citation></ref>
<ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonagh</surname> <given-names>TA</given-names></name> <name><surname>Metra</surname> <given-names>M</given-names></name> <name><surname>Adamo</surname> <given-names>M</given-names></name> <name><surname>Gardner</surname> <given-names>RS</given-names></name> <name><surname>Baumbach</surname> <given-names>A</given-names></name> <name><surname>B&#x00F6;hm</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure</article-title>. <source>Eur Heart J</source>. (<year>2021</year>) <volume>42</volume>(<issue>36</issue>):<fpage>3599</fpage>&#x2013;<lpage>726</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehab368</pub-id><pub-id pub-id-type="pmid">34447992</pub-id></mixed-citation></ref>
<ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname> <given-names>J</given-names></name> <name><surname>Lu</surname> <given-names>J</given-names></name> <name><surname>Tang</surname> <given-names>X</given-names></name> <name><surname>Fang</surname> <given-names>Q.</given-names></name></person-group> <article-title>Association between geriatric nutritional risk Index and depression after ischemic stroke</article-title>. <source>Nutrients</source>. (<year>2022</year>) <volume>14</volume>(<issue>13</issue>):<fpage>2698</fpage>. <pub-id pub-id-type="doi">10.3390/nu14132698</pub-id><pub-id pub-id-type="pmid">35807878</pub-id></mixed-citation></ref>
<ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>L</given-names></name> <name><surname>Chan</surname> <given-names>YK</given-names></name> <name><surname>Busija</surname> <given-names>L</given-names></name> <name><surname>Norekval</surname> <given-names>TM</given-names></name> <name><surname>Riegel</surname> <given-names>B</given-names></name> <name><surname>Stewart</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Malignant and benign phenotypes of multimorbidity in heart failure: implications for clinical practice</article-title>. <source>J Cardiovasc Nurs</source>. (<year>2019</year>) <volume>34</volume>(<issue>3</issue>):<fpage>258</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1097/JCN.0000000000000557</pub-id><pub-id pub-id-type="pmid">30562277</pub-id></mixed-citation></ref>
<ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dent</surname> <given-names>E</given-names></name> <name><surname>Wright</surname> <given-names>ORL</given-names></name> <name><surname>Woo</surname> <given-names>J</given-names></name> <name><surname>Hoogendijk</surname> <given-names>EO.</given-names></name></person-group> <article-title>Malnutrition in older adults</article-title>. <source>Lancet Lond Engl</source>. (<year>2023</year>) <volume>401</volume>(<issue>10380</issue>):<fpage>951</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(22)02612-5</pub-id></mixed-citation></ref>
<ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habaybeh</surname> <given-names>D</given-names></name> <name><surname>de Moraes</surname> <given-names>MB</given-names></name> <name><surname>Slee</surname> <given-names>A</given-names></name> <name><surname>Avgerinou</surname> <given-names>C.</given-names></name></person-group> <article-title>Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or cachexia. A systematic review and meta-analysis</article-title>. <source>Heart Fail Rev</source>. (<year>2021</year>) <volume>26</volume>(<issue>5</issue>):<fpage>1103</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1007/s10741-020-09937-9</pub-id><pub-id pub-id-type="pmid">32124164</pub-id></mixed-citation></ref>
<ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname> <given-names>F</given-names></name> <name><surname>Baumgartner</surname> <given-names>A</given-names></name> <name><surname>Bounoure</surname> <given-names>L</given-names></name> <name><surname>Bally</surname> <given-names>M</given-names></name> <name><surname>Deutz</surname> <given-names>NE</given-names></name> <name><surname>Greenwald</surname> <given-names>JL</given-names></name><etal/></person-group> <article-title>Association of nutritional support with clinical outcomes among medical inpatients who are malnourished or at nutritional risk: an updated systematic review and meta-analysis</article-title>. <source>JAMA Netw Open</source>. (<year>2019</year>) <volume>2</volume>(<issue>11</issue>):<fpage>e1915138</fpage>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.15138</pub-id><pub-id pub-id-type="pmid">31747030</pub-id></mixed-citation></ref>
<ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname> <given-names>L</given-names></name> <name><surname>Shen</surname> <given-names>X</given-names></name> <name><surname>Du</surname> <given-names>Z</given-names></name> <name><surname>Liao</surname> <given-names>J.</given-names></name></person-group> <article-title>Nutritional status and triglyceride-glucose index influence delirium in elderly heart failure patients</article-title>. <source>Sci Rep</source>. (<year>2024</year>) <volume>14</volume>(<issue>1</issue>):<fpage>25235</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-024-77573-6</pub-id><pub-id pub-id-type="pmid">39448708</pub-id></mixed-citation></ref>
<ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belinskaia</surname> <given-names>DA</given-names></name> <name><surname>Voronina</surname> <given-names>PA</given-names></name> <name><surname>Shmurak</surname> <given-names>VI</given-names></name> <name><surname>Jenkins</surname> <given-names>RO</given-names></name> <name><surname>Goncharov</surname> <given-names>NV.</given-names></name></person-group> <article-title>Serum albumin in health and disease: esterase, antioxidant, transporting and signaling properties</article-title>. <source>Int J Mol Sci</source>. (<year>2021</year>) <volume>22</volume>(<issue>19</issue>):<fpage>10318</fpage>. <pub-id pub-id-type="doi">10.3390/ijms221910318</pub-id><pub-id pub-id-type="pmid">34638659</pub-id></mixed-citation></ref>
<ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vest</surname> <given-names>AR</given-names></name> <name><surname>Chan</surname> <given-names>M</given-names></name> <name><surname>Deswal</surname> <given-names>A</given-names></name> <name><surname>Givertz</surname> <given-names>MM</given-names></name> <name><surname>Lekavich</surname> <given-names>C</given-names></name> <name><surname>Lennie</surname> <given-names>T</given-names></name><etal/></person-group> <article-title>Nutrition, obesity, and cachexia in patients with heart failure: a consensus statement from the heart failure society of America scientific statements committee</article-title>. <source>J Card Fail</source>. (<year>2019</year>) <volume>25</volume>(<issue>5</issue>):<fpage>380</fpage>&#x2013;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardfail.2019.03.007</pub-id><pub-id pub-id-type="pmid">30877038</pub-id></mixed-citation></ref>
<ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jorge-Huerta</surname> <given-names>L</given-names></name> <name><surname>Marco-Alacid</surname> <given-names>C</given-names></name> <name><surname>Grande</surname> <given-names>C</given-names></name> <name><surname>Andr&#x00E9;s</surname> <given-names>CV.</given-names></name></person-group> <article-title>A narrative review of the diagnosis and treatment of sarcopenia and malnutrition in patients with heart failure</article-title>. <source>Nutrients</source>. (<year>2024</year>) <volume>16</volume>(<issue>16</issue>):<fpage>2717</fpage>. <pub-id pub-id-type="doi">10.3390/nu16162717</pub-id><pub-id pub-id-type="pmid">39203852</pub-id></mixed-citation></ref>
<ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arvunescu</surname> <given-names>AM</given-names></name> <name><surname>Ionescu</surname> <given-names>RF</given-names></name> <name><surname>Dumitrescu</surname> <given-names>SI</given-names></name> <name><surname>Zaharia</surname> <given-names>O</given-names></name> <name><surname>Nanea</surname> <given-names>IT.</given-names></name></person-group> <article-title>The real-world anti-inflammatory effect of SGLT2i in patients with chronic heart failure</article-title>. <source>J Med Life</source>. (<year>2025</year>) <volume>18</volume>(<issue>2</issue>):<fpage>155</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.25122/jml-2025-0011</pub-id><pub-id pub-id-type="pmid">40134442</pub-id></mixed-citation></ref>
<ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amaechi</surname> <given-names>UM</given-names></name> <name><surname>Aiwuyo</surname> <given-names>HO</given-names></name> <name><surname>Ewelukwa</surname> <given-names>C</given-names></name> <name><surname>Ilerhunmwuwa</surname> <given-names>N</given-names></name> <name><surname>Osarenkhoe</surname> <given-names>JO</given-names></name> <name><surname>Kweki</surname> <given-names>AG</given-names></name><etal/></person-group> <article-title>Assessing iron status in chronic heart failure patients by using Serum ferritin and transferrin saturation levels: a cross-sectional descriptive study</article-title>. <source>Cureus</source>. (<year>2023</year>) <volume>15</volume>(<issue>5</issue>):<fpage>e39425</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.39425</pub-id><pub-id pub-id-type="pmid">37362450</pub-id></mixed-citation></ref>
<ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cereda</surname> <given-names>E</given-names></name> <name><surname>Vanotti</surname> <given-names>A</given-names></name></person-group>. <article-title>The new geriatric nutritional risk index is a good predictor of muscle dysfunction in institutionalized older patients</article-title>. <source>Clin Nutr Edinb Scotl</source>. (<year>2007</year>) <volume>26</volume>(<issue>1</issue>):<fpage>78</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2006.09.007</pub-id></mixed-citation></ref>
<ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narumi</surname> <given-names>T</given-names></name> <name><surname>Arimoto</surname> <given-names>T</given-names></name> <name><surname>Funayama</surname> <given-names>A</given-names></name> <name><surname>Kadowaki</surname> <given-names>S</given-names></name> <name><surname>Otaki</surname> <given-names>Y</given-names></name> <name><surname>Nishiyama</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Prognostic importance of objective nutritional indexes in patients with chronic heart failure</article-title>. <source>J Cardiol</source>. (<year>2013</year>) <volume>62</volume>(<issue>5</issue>):<fpage>307</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.jjcc.2013.05.007</pub-id><pub-id pub-id-type="pmid">23806549</pub-id></mixed-citation></ref>
<ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iida</surname> <given-names>Y</given-names></name> <name><surname>Kamiya</surname> <given-names>K</given-names></name> <name><surname>Adachi</surname> <given-names>T</given-names></name> <name><surname>Iwatsu</surname> <given-names>K</given-names></name> <name><surname>Kamisaka</surname> <given-names>K</given-names></name> <name><surname>Iritani</surname> <given-names>N</given-names></name><etal/></person-group> <article-title>Prognostic impact of nutrition measures in patients with heart failure varies with coexisting physical frailty</article-title>. <source>esc Heart Fail</source>. (<year>2023</year>) <volume>10</volume>(<issue>6</issue>):<fpage>3364</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1002/ehf2.14519</pub-id><pub-id pub-id-type="pmid">37675757</pub-id></mixed-citation></ref>
<ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishi</surname> <given-names>I</given-names></name> <name><surname>Seo</surname> <given-names>Y</given-names></name> <name><surname>Hamada-Harimura</surname> <given-names>Y</given-names></name> <name><surname>Yamamoto</surname> <given-names>M</given-names></name> <name><surname>Ishizu</surname> <given-names>T</given-names></name> <name><surname>Sugano</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Geriatric nutritional risk index predicts all-cause deaths in heart failure with preserved ejection fraction</article-title>. <source>ESC Heart Fail</source>. (<year>2019</year>) <volume>6</volume>(<issue>2</issue>):<fpage>396</fpage>&#x2013;<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1002/ehf2.12405</pub-id><pub-id pub-id-type="pmid">30706996</pub-id></mixed-citation></ref>
<ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshihisa</surname> <given-names>A</given-names></name> <name><surname>Kanno</surname> <given-names>Y</given-names></name> <name><surname>Watanabe</surname> <given-names>S</given-names></name> <name><surname>Yokokawa</surname> <given-names>T</given-names></name> <name><surname>Abe</surname> <given-names>S</given-names></name> <name><surname>Miyata</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Impact of nutritional indices on mortality in patients with heart failure</article-title>. <source>Open Heart</source>. (<year>2018</year>) <volume>5</volume>(<issue>1</issue>):<fpage>e000730</fpage>. <pub-id pub-id-type="doi">10.1136/openhrt-2017-000730</pub-id><pub-id pub-id-type="pmid">29344381</pub-id></mixed-citation></ref></ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by"><p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1072721/overview">Rita Pavasini</ext-link>, University Hospital of Ferrara, Italy</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by"><p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/798770/overview">Najla Kharrat</ext-link>, Centre of Biotechnology of Sfax, Tunisia</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1305989/overview">Nicolas Padilla-Raygoza</ext-link>, Institute of Public Health of the State of Guanajuato (ISAPEG), Mexico</p></fn>
<fn fn-type="abbr" id="abbrev1"><p><bold>Abbreviations</bold> CHF, chronic heart failure; Alb, albumin; Hb, hemoglobin; GNRI, geriatric nutritional risk index; LAD, left atrial diameter; LVDs, left ventricular end-systolic diameter; LVDd, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; hs-CRP, high-sensitivity C-reactive protein; NT-proBNP, N-terminal pro-brain natriuretic peptide.</p></fn>
</fn-group>
</back>
</article>